Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
GCLM
Introduction
Glutamate-cysteine ligase regulatory subunit is an enzyme that in humans is encoded by the GCLM gene.[1][2]
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase, is the first rate limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subuit and a light regulatory subunit. Gamma glutamylcysteine synthetase deficiency has been implicated in some forms of hemolytic anemia.[2]
References
References
- ↑ Gipp JJ, Bailey HH, Mulcahy RT (Feb 1995). “Cloning and sequencing of the cDNA for the light subunit of human liver gamma-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in human normal tissues”. Biochem Biophys Res Commun. 206 (2): 584–9. doi:10.1006/bbrc.1995.1083. PMID 7826375.
- ↑ 2.0 2.1 “Entrez Gene: GCLM glutamate-cysteine ligase, modifier subunit”.
Further reading
Further reading
- Dickinson DA, Levonen AL, Moellering DR, et al. (2005). “Human glutamate cysteine ligase gene regulation through the electrophile response element”. Free Radic. Biol. Med. 37 (8): 1152–9. doi:10.1016/j.freeradbiomed.2004.06.011. PMID 15451055.
- Robertson NG, Khetarpal U, Gutiérrez-Espeleta GA, et al. (1995). “Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening”. Genomics. 23 (1): 42–50. doi:10.1006/geno.1994.1457. PMID 7829101.
- Tsuchiya K, Mulcahy RT, Reid LL, et al. (1997). “Mapping of the glutamate-cysteine ligase catalytic subunit gene (GLCLC) to human chromosome 6p12 and mouse chromosome 9D-E and of the regulatory subunit gene (GLCLR) to human chromosome 1p21-p22 and mouse chromosome 3H1-3”. Genomics. 30 (3): 630–2. doi:10.1006/geno.1995.1293. PMID 8825659.
- Sierra-Rivera E, Dasouki M, Summar ML, et al. (1997). “Assignment of the human gene (GLCLR) that encodes the regulatory subunit of gamma-glutamylcysteine synthetase to chromosome 1p21”. Cytogenet. Cell Genet. 72 (2–3): 252–4. doi:10.1159/000134202. PMID 8978789.
- Misra I, Griffith OW (1998). “Expression and purification of human gamma-glutamylcysteine synthetase”. Protein Expr. Purif. 13 (2): 268–76. doi:10.1006/prep.1998.0897. PMID 9675072.
- Rozet JM, Gerber S, Perrault I, et al. (1998). “Structure and refinement of the physical mapping of the gamma- glutamylcysteine ligase regulatory subunit (GLCLR) gene to chromosome 1p22.1 within the critically deleted region of human malignant mesothelioma”. Cytogenet. Cell Genet. 82 (1–2): 91–4. doi:10.1159/000015072. PMID 9841137.
- Tu Z, Anders MW (1999). “Identification of an important cysteine residue in human glutamate-cysteine ligase catalytic subunit by site-directed mutagenesis”. Biochem. J. 336 (3): 675–80. PMC 1219919. PMID 9841880.
- Tipnis SR, Blake DG, Shepherd AG, McLellan LI (1999). “Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance”. Biochem. J. 337 (3): 559–66. doi:10.1042/0264-6021:3370559. PMC 1220010. PMID 9895302.
- Galloway DC, Blake DG, McLellan LI (1999). “Regulation of gamma-glutamylcysteine synthetase regulatory subunit (GLCLR) gene expression: identification of the major transcriptional start site in HT29 cells”. Biochim. Biophys. Acta. 1446 (1–2): 47–56. doi:10.1016/S0167-4781(99)00073-1. PMID 10395918.
- Levonen AL, Lapatto R, Saksela M, Raivio KO (2000). “Expression of gamma-glutamylcysteine synthetase during development”. Pediatr. Res. 47 (2): 266–70. doi:10.1203/00006450-200002000-00019. PMID 10674357.
- Nakamura S, Kugiyama K, Sugiyama S, et al. (2002). “Polymorphism in the 5′-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction”. Circulation. 105 (25): 2968–73. doi:10.1161/01.CIR.0000019739.66514.1E. PMID 12081989.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Nakamura S, Sugiyama S, Fujioka D, et al. (2003). “Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function”. Circulation. 108 (12): 1425–7. doi:10.1161/01.CIR.0000091255.63645.98. PMID 12975258.
- Inoue Y, Tomisawa M, Yamazaki H, et al. (2004). “The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer”. Int. J. Oncol. 23 (5): 1333–9. doi:10.3892/ijo.23.5.1333. PMID 14532974.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Song IS, Tatebe S, Dai W, Kuo MT (2005). “Delayed mechanism for induction of gamma-glutamylcysteine synthetase heavy subunit mRNA stability by oxidative stress involving p38 mitogen-activated protein kinase signaling”. J. Biol. Chem. 280 (31): 28230–40. doi:10.1074/jbc.M413103200. PMID 15946948.
- Chen Y, Shertzer HG, Schneider SN, et al. (2005). “Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels”. J. Biol. Chem. 280 (40): 33766–74. doi:10.1074/jbc.M504604200. PMID 16081425.
- Diaz-Hernandez JI, Almeida A, Delgado-Esteban M, et al. (2006). “Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons”. J. Biol. Chem. 280 (47): 38992–9001. doi:10.1074/jbc.M507065200. PMID 16183645.